Brief: Sedana Medical Q4 EBIT Loss Narrows To SEK 10.8 Mln
Feb 13 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* Q4 NET SALES FOR QUARTER TOTALLED MSEK 49.2 (44.5)
* Q4 GROSS PROFIT WAS MSEK 34.2 (31.0) EQUIVALENT TO A
MARGIN OF
69% (70%)
* Q4 OPERATING INCOME (EBIT) TOTALLED MSEK -10.8 (-14.8),
EQUIVALENT TO AN EBIT MARGIN OF -22% (-33%)
Source text: ID:nMFN9KXtld
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln